20 (AIDX) Accumulated Expenses (2024 - 2026)

20 (AIDX) reported Accumulated Expenses of $598335.0 for Q1 2026, down 23.86% quarter-over-quarter from $785784.0 in Q4 2025.

20 (AIDX) Accumulated Expenses (2024 - 2026) Analysis & Trends

20 has reported Accumulated Expenses for 3 years, with the latest figure at $598335.0 in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses changed N/A year-over-year to $598335.0; the trailing twelve-month figure through Mar 2026 stood at $598335.0 (changed N/A YoY), and the FY2025 full-year result was $785784.0, up 126.7% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $598335.0, down from $785784.0 in the prior quarter.
  • The five-year high for Accumulated Expenses was $785784.0 in Q4 2025, with the low at $346622.0 in Q4 2024.
  • Historically, Accumulated Expenses has averaged $576913.7 across 3 years, with a median of $598335.0 in 2026.
  • The largest YoY upside for Accumulated Expenses was 126.7% in 2025 against a maximum downside of 126.7% in 2025.
  • 20's Accumulated Expenses stood at $346622.0 in 2024, then soared by 126.7% to $785784.0 in 2025, then retreated by 23.86% to $598335.0 in 2026.
  • The last three Accumulated Expenses figures came in at $598335.0 (Q1 2026), $785784.0 (Q4 2025), and $346622.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 20 - - 62,884.00

Historic Data

Download Data
DateValue
Mar 31, 2026 598,335.00
Dec 31, 2025 785,784.00
Dec 31, 2024 346,622.00